Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.2.2
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Private Placement
Convertible preferred stock (as converted to common stock)
Common Stock
Common Stock
Private Placement
Additional Paid-in Capital
Additional Paid-in Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057                
Balance at the beginning at Dec. 31, 2020 $ 75,877                
Balance at the end (in shares) at Mar. 31, 2021 [1] 77,340,057                
Balance at the end at Mar. 31, 2021 $ 75,877                
Balance at the beginning (in shares) at Dec. 31, 2020 [1]       9,846,830          
Balance at the beginning at Dec. 31, 2020 (84,805)     $ 1   $ 10,110   $ 0 $ (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) [1]       1,563,281          
Issuance of common stock upon net exercise of stock options 455         455      
Stock-based compensation cost 321         321      
Net loss (13,506)               (13,506)
Issuance of warrant to purchase common stock 1         1      
Balance at the end (in shares) at Mar. 31, 2021 [1]       11,410,111          
Balance at the end at Mar. 31, 2021 $ (97,534)     $ 1   10,887   0 (108,422)
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057                
Balance at the beginning at Dec. 31, 2020 $ 75,877                
Balance at the end (in shares) at Jun. 30, 2021 [1] 77,340,057                
Balance at the end at Jun. 30, 2021 $ 75,877                
Balance at the beginning (in shares) at Dec. 31, 2020 [1]       9,846,830          
Balance at the beginning at Dec. 31, 2020 (84,805)     $ 1   10,110   0 (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (36,483)                
Balance at the end (in shares) at Jun. 30, 2021 [1]       13,359,527          
Balance at the end at Jun. 30, 2021 $ (119,226)     $ 1   12,172   0 (131,399)
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057                
Balance at the beginning at Dec. 31, 2020 $ 75,877                
Balance at the end (in shares) at Sep. 30, 2021 [1] 0                
Balance at the end at Sep. 30, 2021 $ 0                
Balance at the beginning (in shares) at Dec. 31, 2020 [1]       9,846,830          
Balance at the beginning at Dec. 31, 2020 (84,805)     $ 1   10,110   0 (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative translation adjustment 0                
Net loss (15,676)                
Balance at the end (in shares) at Sep. 30, 2021 [1]       142,335,990          
Balance at the end at Sep. 30, 2021 $ 282,107     $ 14   392,685   0 (110,592)
Balance at the beginning (in shares) at Dec. 31, 2020 [1] 77,340,057                
Balance at the beginning at Dec. 31, 2020 $ 75,877                
Balance at the end (in shares) at Dec. 31, 2021 0                
Balance at the beginning (in shares) at Dec. 31, 2020 [1]       9,846,830          
Balance at the beginning at Dec. 31, 2020 $ (84,805)     $ 1   10,110   0 (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (10,888)                
Issuance of warrant to purchase common stock 0                
Balance at the end (in shares) at Dec. 31, 2021 [1]       142,745,021          
Balance at the end at Dec. 31, 2021 $ 290,274     $ 14   396,064   0 (105,804)
Balance at the beginning (in shares) at Mar. 31, 2021 [1] 77,340,057                
Balance at the beginning at Mar. 31, 2021 $ 75,877                
Balance at the end (in shares) at Jun. 30, 2021 [1] 77,340,057                
Balance at the end at Jun. 30, 2021 $ 75,877                
Balance at the beginning (in shares) at Mar. 31, 2021 [1]       11,410,111          
Balance at the beginning at Mar. 31, 2021 (97,534)     $ 1   10,887   0 (108,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) [1]       1,993,081          
Issuance of common stock upon net exercise of stock options 202         202      
Stock-based compensation cost 1,083         1,083      
Net loss (22,977)               (22,977)
Issuance of warrant to purchase common stock 0                
Repurchase of common stock upon settlement of related party note (in shares) [1]       (43,665)          
Balance at the end (in shares) at Jun. 30, 2021 [1]       13,359,527          
Balance at the end at Jun. 30, 2021 $ (119,226)     $ 1   12,172   0 (131,399)
Balance at the end (in shares) at Sep. 30, 2021 [1] 0                
Balance at the end at Sep. 30, 2021 $ 0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) [1]       311,722          
Issuance of common stock upon net exercise of stock options 120         120      
Issuance of common stock upon vesting of restricted stock units (in shares) [1]       1,837          
Stock-based compensation cost 3,124         3,124      
Cumulative translation adjustment 0                
Net loss 20,807               20,807
Initial fair value of contingent earn-out liability recognized upon the closing of the Merger (67,021)         (67,021)      
Initial fair value of contingently issuable common stock liability recognized upon the closing of the Merger (11,670)         (11,670)      
Balance at the end (in shares) at Sep. 30, 2021 [1]       142,335,990          
Balance at the end at Sep. 30, 2021 $ 282,107     $ 14   392,685   0 (110,592)
Balance at the beginning (in shares) at Dec. 31, 2021 0                
Balance at the beginning (in shares) at Dec. 31, 2021 [1]       142,745,021          
Balance at the beginning at Dec. 31, 2021 $ 290,274     $ 14   396,064   0 (105,804)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) [1]       496,971          
Issuance of common stock upon net exercise of stock options 226         226      
Issuance of common stock upon vesting of restricted stock units (in shares) [1]       80,044          
Stock-based compensation cost 3,953         3,953      
Net loss (13,801)               (13,801)
Balance at the end (in shares) at Mar. 31, 2022 [1]       143,322,036          
Balance at the end at Mar. 31, 2022 $ 280,652     $ 14   400,243   0 (119,605)
Balance at the beginning (in shares) at Dec. 31, 2021 0                
Balance at the beginning (in shares) at Dec. 31, 2021 [1]       142,745,021          
Balance at the beginning at Dec. 31, 2021 $ 290,274     $ 14   396,064   0 (105,804)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 1,278,014                
Cumulative translation adjustment $ 35                
Net loss (58,102)                
Balance at the end (in shares) at Sep. 30, 2022 [1]       144,434,717          
Balance at the end at Sep. 30, 2022 248,381     $ 14   412,238   35 (163,906)
Balance at the beginning (in shares) at Mar. 31, 2022 [1]       143,322,036          
Balance at the beginning at Mar. 31, 2022 280,652     $ 14   400,243   0 (119,605)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) [1]       350,092          
Issuance of common stock upon net exercise of stock options 157         157      
Issuance of common stock upon vesting of restricted stock units (in shares) [1]       157,867          
Stock-based compensation cost 5,093         5,093      
Cumulative translation adjustment (10)             (10)  
Net loss (25,686)               (25,686)
Balance at the end (in shares) at Jun. 30, 2022 [1]       143,829,995          
Balance at the end at Jun. 30, 2022 260,206     $ 14   405,493   (10) (145,291)
Convertible Preferred Stock                  
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger (in shares)     (77,340,057)            
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger     $ (75,877)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) [1]       428,155          
Issuance of common stock upon net exercise of stock options 188         188      
Issuance of common stock upon vesting of restricted stock units (in shares) [1]       176,567          
Stock-based compensation cost 6,557         6,557      
Cumulative translation adjustment 45             45  
Net loss (18,615)               (18,615)
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger (in shares) [1]       80,833,007          
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger 75,877     $ 8   75,869      
Issuance of common stock in connection with the closing of the Merger (in shares) [1]       10,391,513          
Issuance of common stock in connection with the closing of the Merger 84,945     $ 1   84,944      
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) [1]         30,000,000        
Issuance of common stock in connection with the consummation of the PIPE Investment   $ 300,000     $ 3   $ 299,997    
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger (in shares) [1]       2,029,712          
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger 880         880      
Issuance of common stock for the conversion of convertible notes (in shares) [1]       5,408,672          
Issuance of common stock for the conversion of convertible notes 53,645     $ 1   53,644      
Issuance of public warrant in connection with the closing of the Merger (23,636)         (23,636)      
Payment of deferred offering costs in connection with the closing of the Merger and PIPE Investment (35,738)         (35,738)      
Balance at the end (in shares) at Sep. 30, 2022 [1]       144,434,717          
Balance at the end at Sep. 30, 2022 $ 248,381     $ 14   $ 412,238   $ 35 $ (163,906)
[1] The shares of the Company’s convertible preferred stock and common stock, prior to the Merger (as defined in Note 3) have been retrospectively restated to reflect the exchange ratio of 0.378 established in the Merger as described in Note 3.